L'epidemia di Ebola in Congo continua a diffondersi rapidamente, con oltre 3.000 morti

The Ebola outbreak in the Democratic Republic of Congo has shown no signs of slowing down, with confirmed cases surpassing 6,100 and deaths exceeding 3,000, according to government data released on Wednesday. The rapid spread of the virus continues to outpace containment efforts, marking it as the fastest-growing Ebola outbreak ever recorded. Since the declaration of a global health emergency in mid-May, the Ministry of Health reported 6,186 confirmed cases, including 3,007 fatalities. The outbreak has expanded into six provinces, with recent weeks seeing a sharp increase in infections, particularly in two newly affected health zones in North Kivu, where the fatality rate is significantly higher than in other affected regions. Health workers have been operating under extremely challenging conditions, often facing attacks and demanding better pay through strikes. The spread of the disease has been fueled by multiple factors, including ongoing conflict in the eastern part of the country, assaults on medical personnel, high mobility among miners, and inadequate healthcare infrastructure. Concerns have also arisen over the resumption of school classes during the outbreak, raising fears of transmission within classrooms. According to a report issued by the U.S. Centers for Disease Control and Prevention on Tuesday, efforts to contain the virus remain below established response targets. The rapid spread in many health zones indicates an "uncontrolled expansion of the outbreak." The World Health Organization warned that this outbreak could soon surpass the deadliest previous Ebola epidemic, which occurred in West Africa between 2014 and 2016 and claimed 11,000 lives. African CDC officials noted that the true number of cases might be three times higher due to deficiencies in surveillance and contact tracing. The current outbreak is caused by the rare Bundibugyo strain of the Ebola virus, for which there is currently no approved vaccine or treatment. However, a few vaccines are in development. Last week, the government began distributing the Ervebo vaccine to frontline healthcare workers in Kisangani, located in the northeastern Tshopo region. This vaccine has previously helped control earlier outbreaks and, according to the WHO, may offer some level of protection against infection. The situation has drawn international attention, with the U.S. CDC highlighting the inadequacy of response measures. Local health authorities continue to struggle with limited resources and security challenges, complicating their ability to trace contacts and isolate infected individuals effectively. Despite these obstacles, the distribution of Ervebo represents a critical step in bolstering defenses against the virus’s spread. The outbreak has placed immense pressure on local healthcare systems already strained by years of instability and conflict. In areas such as North Kivu, where the fatality rate is alarmingly high, the combination of poor healthcare access and community resistance to interventions further exacerbates the crisis. Efforts to vaccinate healthcare workers aim to create a buffer against potential infections, but broader vaccination campaigns face logistical hurdles and public skepticism. As the outbreak continues to evolve, health officials warn that the situation remains fluid and unpredictable. The virus's rapid spread underscores the need for sustained international support and improved coordination between local and global health agencies. With no immediate end in sight, the focus remains on containing the outbreak and preventing its spread to new regions. The latest data confirms that the battle against Ebola in the Democratic Republic of Congo is far from over.